Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

Donna k McClish, PhD, Wally R. Smith, MD, Joshua J. Field, MD, Samir K. Ballas, MD, Claudia M Campbell, PhD, Lori E. Crosby, PhD, Carlton Dampier, MD, Deepika S. Darbari, MD, William Zempsky, MD

Blood (2018) 132 (Supplement 1): 3510.

https://doi.org/10.1182/blood-2018-99-114830

Published: 2018

Journal Articles

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

Yankai Zhang, PhD, Samir K. Ballas, MD, Vivien A Sheehan, MD PhD

Blood (2018) 132 (Supplement 1): 1071.

https://doi.org/10.1182/blood-2018-99-116936

Published: 2018

Journal Articles

Re-Assessing the Red Blood Cell Lifespan in Sickle Cell Anemia: Does Size Matter?

Norman Alan Mazer, MD PhD, Tomas Tomka, BS, MS, Michael Winter, PhD DVM,, Annette Koerner, PhD, Samir K. Ballas, MD

Blood (2018) 132 (Supplement 1): 4877.

https://doi.org/10.1182/blood-2018-99-110592

Published: 2018

Journal Articles

Quality of Care in United States Children with Sickle Cell Anemia

Julie Kanter, MD, Carlton Dampier, MD, Irene Agodoa, MD, Robin Howard, Sally Wade, Virginia Noxon, PhD, Samir K. Ballas, MD

Blood (2017) 130 (Supplement 1): 2098.

https://doi.org/10.1182/blood.V130.Suppl_1.2098.2098

Published: 2017

Journal Articles

A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome

Smith Giri, MBBS, Samir K. Ballas, MD, Michelle Deveaux, Vu H. Duong, MD, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 3734.

https://doi.org/10.1182/blood.V130.Suppl_1.3734.3734

Published: 2017

Journal Articles

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Samir K. Ballas, MD, Vu H. Duong, MD, Michelle Deveaux, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 3743.

https://doi.org/10.1182/blood.V130.Suppl_1.3743.3743

Published: 2017

Journal Articles

Access to Care for Medicaid and Commercially-Insured United States Patients with Sickle Cell Disease

Carlton Dampier, MD, Julie Kanter, MD, Robin Howard, Irene Agodoa, MD, Sally Wade, Virginia Noxon, PhD, Samir K. Ballas, MD

Blood (2017) 130 (Supplement 1): 4660.

https://doi.org/10.1182/blood.V130.Suppl_1.4660.4660

Published: 2017

Journal Articles

Opioid Utilization Patterns in United States Patients with Sickle Cell Disease

Samir K. Ballas, MD, Julie Kanter, MD, Irene Agodoa, MD, Robin Howard, Sally Wade, Virginia Noxon, PhD, Carlton Dampier, MD

Blood (2017) 130 (Supplement 1): 130.

https://doi.org/10.1182/blood.V130.Suppl_1.130.130

Published: 2017

Journal Articles

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Samir K. Ballas, MD

Blood (2016) 128 (22): 2498.

https://doi.org/10.1182/blood.V128.22.2498.2498

Published: 2016

Journal Articles

Efficacy of Lidocaine Patch in Relieving Severe Sickle Cell Leg Ulcer Pain

Clarisse Lopes de Castro Lobo, ASH, MEMBER, Ana Maria Mach Queiroz, MD, Agueda Gloria Sabino De Matos, Eleonora D'Avila Thome, Samir K. Ballas, MD

Blood (2015) 126 (23): 4596.

https://doi.org/10.1182/blood.V126.23.4596.4596

Published: 2015

Journal Articles

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Dianne Pulte, MD, Gaye Riddick-Burden, MSN, Samir K. Ballas, MD

Blood (2015) 126 (23): 4599.

https://doi.org/10.1182/blood.V126.23.4599.4599

Published: 2015

Journal Articles

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

Edward P Armstrong, Pharm.D, Grant H Skrepnek, PhD, Samir K. Ballas, MD, Peter Kwok, Pharm.D, Susan Snodgrass, MD, Medha Sasane, PhD

Blood (2011) 118 (21): 3152.

https://doi.org/10.1182/blood.V118.21.3152.3152

Published: 2011

Journal Articles

High Mortality Among Children with Sickle Cell Anemia and Stroke Who Discontinue Chronic Blood Transfusion After Transition to An Adult Program

Samir K. Ballas, MD

Blood (2010) 116 (21): 1629.

https://doi.org/10.1182/blood.V116.21.1629.1629

Published: 2010

Journal Articles

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

F. Daniel Armstrong, Ph.D., Martin H Steinberg, MD, Samir K. Ballas, MD, Kenneth I. Ataga, MD, Myron A Waclawiw, PhD, Abdullah Kutlar, MD, Paul S. Swerdlow, MD, William F. McCarthy, Ph., D., for the MSH Extension Investigators

Blood (2009) 114 (22): 1543.

https://doi.org/10.1182/blood.V114.22.1543.1543

Published: 2009

Journal Articles

Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.

Samir K. Ballas, MD, Robert L Bauserman, PhD, William F. McCarthy, Ph., D., Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2485.

https://doi.org/10.1182/blood.V114.22.2485.2485

Published: 2009

Journal Articles

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert I Bauseman, PhD, Oswaldo L Castro, MD, Paul S. Swerdlow, MD, Wally Smith, Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2577.

https://doi.org/10.1182/blood.V114.22.2577.2577

Published: 2009

Journal Articles

Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert L Bauserman, PhD, Oswaldo L Castro, MD, Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2582.

https://doi.org/10.1182/blood.V114.22.2582.2582

Published: 2009

Journal Articles

Footprints of Response to Hydroxyurea Are in the Hemogram.

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Nan Gua, Carlo Brugnara, MD, Gail M Kling, MS, Robert L Bauserman, PhD, Myron A Waclawiw, PhD

Blood (2009) 114 (22): 4619.

https://doi.org/10.1182/blood.V114.22.4619.4619

Published: 2009

Journal Articles

Stroke in Sickle Cell Anemia After Excellent Response to Hydroxyurea.

Ubaldo Martinez, MD, Samir K. Ballas, MD

Blood (2009) 114 (22): 4622.

https://doi.org/10.1182/blood.V114.22.4622.4622

Published: 2009

Journal Articles

Definition of the Responder to Hydroxyurea Therapy: Revisited.

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert L Bauserman, Ph.D, Faramarz Valafar, Myron Waclawiw, Bruce A Barton, PhD, Abdullah Kutlar, MD

Blood (2009) 114 (22): 1513.

https://doi.org/10.1182/blood.V114.22.1513.1513

Published: 2009

NARROW

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

Re-Assessing the Red Blood Cell Lifespan in Sickle Cell Anemia: Does Size Matter?

Quality of Care in United States Children with Sickle Cell Anemia

A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome

A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and β-Thalassemia

Access to Care for Medicaid and Commercially-Insured United States Patients with Sickle Cell Disease

Opioid Utilization Patterns in United States Patients with Sickle Cell Disease

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Efficacy of Lidocaine Patch in Relieving Severe Sickle Cell Leg Ulcer Pain

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

High Mortality Among Children with Sickle Cell Anemia and Stroke Who Discontinue Chronic Blood Transfusion After Transition to An Adult Program

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Footprints of Response to Hydroxyurea Are in the Hemogram.

Stroke in Sickle Cell Anemia After Excellent Response to Hydroxyurea.

Definition of the Responder to Hydroxyurea Therapy: Revisited.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only